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Abstract
BACKGROUND: In the age of modern medicine, thanks to the development of small-caliber nephroscope as well 
as various types of intracorporeal lithotripters, treatment options for renal stones have changed dramatically, and 
the area of percutaneous nephrolithotomy (PCNL) has expanded. Nowadays, PCNL is not only the first choice in 
the treatment of stones >2 cm, as well as complicated renal stones (staghorn stones, multiple stones, and stones 
associated with abnormal renal anatomy), but is also the method of optimal treatment for medium-sized stones not 
treated with other less invasive methods.
AIM: The purpose of this study is to assess the efficacy and safety of PCNL as monotherapy in the treatment of renal 
stones larger than 15 mm.
MATERIALS AND METHODS: This study presents a retrospectively prospective study of 14 (4 retrospective and 10 
prospective) consecutive patients with renal stones larger than 15 mm treated with PCNL in the period from January 
2020 to March 2020 at the GH “8 September” – Skopje. Pre-operative preparation of patients included: A history 
along with physical examination, a complete blood count and radiological examinations to assess the size of the 
stones, the anatomical features of the kidney and its function, and to accurately plan the operative approach. PCNL 
was performed in the prone-position; lithotripsy was performed with a double, pneumatic and ultrasonic intracorporeal 
lithotripter Swiss LithoClast Master with the use of the Karl Storz 24–26 fr nephroscope. Postoperatively, patients 
were monitored on the 1st, 7th, and 30th post-operative day, determining the demographic and clinical characteristics, 
the efficacy of PCNL, perioperative blood loss, the duration of the operative procedure, the duration of hospital stay, 
and the resulting intraoperative and post-operative complications.
RESULTS: The study included eight men (57.1%) and six women (42.8%). The mean age of the patients was 52.35 ± 
11.00. In 5 (35.71%) patients, the stones were localized in the left kidney, and in 9 (64.28%) patients in the right kidney. 
The average body mass index was 25.11 ± 3.92 kg/m². The average area of the stones was 371.24 ± 131.86 mm². 
Eleven (78.57%) patients had simplex stones, while 3 (21.42%) had complex stones (staghorn stones and multiple 
stones). The stones were localized in the renal pelvis, upper, middle, and lower calyx at 5 (35.71%), 2 (14.28%), 4 
(28.57%), and 3 (21.42%) patients, respectively. The mean value of pre- and post-operative serum hemoglobin was 
13.94 ± 1.00 g/dl and 11.77 ± 1.51 g/dl, respectively. The effectiveness of the procedure on the 1st post-operative day 
assessed by ultrasound diagnostics and kidney-ureter-bladder X-ray was 78.57%. The success rate on the 30th post-
operative day after additional procedures was 92.85%. The average operating time in the entire series was 119.28 
± 9.42 min. The average hospital stay was 5.57 ± 1.11 days. The average operative blood loss was 2.19 ± 0.88 g/dl.
CONCLUSION: The results of this retrospectively prospective study confirm that PCNL is a minimally invasive, safe, 
and effective method for removing renal stones. This method, with the development of new technologies, has an 
increasingly important role in the modern surgical treatment of nephrolithiasis. PCNL can also be performed in the early 
stages of the learning curve without compromising patient safety and treatment benefits. The procedure is safe and 
effective, performed even by less experienced urologists if the protocols established for this procedure are followed. 
This can achieve a rate of success comparable to most established standards without causing major complications.
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Introduction
In the age of modern medicine, urolithiasis 
continues to be one of the major diseases in the daily 
practice of urologists. Due to the low morbidity and 
excellent fragmentation of the stones, extracorporeal 
shock wave lithotripsy (ESWL) has long been 
recommended as the first line of treatment for most 
patients with stone disease. However, thanks to 
the development of small-caliber nephroscope, as 
well as various types of intracorporeal lithotripters, 
nephroscopy has become a much less invasive 
and easily feasible method with a small number 
of complications. This significant improvement in 
urological armamentarium has led to endourological 
techniques being more attractive and effective in the 
treatment of nephrolithiasis [1], [2].
Percutaneous nephrolithotomy (PCNL) since its 
initial introduction in 1976 by Fernstrom and Johansson, 
has been widely used in the treatment of large renal 
stones and remains the gold standard for the treatment 
of complicated renal stones (staghorn stones, multiple 
stones, stones associated with abnormal renal anatomy, 
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and stones that are not treated with other less invasive 
methods) [3]. However, although PCNL is considered a 
minimally invasive procedure, it is still a surgical technique 
that can be associated with critical complications such as 
bleeding and septicemia, which has led to many efforts 
to reduce morbidity and increase the effectiveness 
and efficacy of PCNL because PCNL remains the first 
treatment line indicated for many cases [4], [5].
In this combined retrospectively prospective 
study, we present our initial experiences in the 
implementation of PCNL in our institution.
Objective
The purpose of this study is to assess the 
efficacy and safety of PCNL as monotherapy in 
the treatment of renal stones larger than 15 mm by 
determining the stone-free rate – SFR, the need for 
additional procedures, the degree of complications 
after treatment, the degree of blood loss, the duration 
of the procedure, and the duration of hospital stay.
Materials and Methods
We performed a retrospectively prospective 
study in 14 (4 retrospective and 10 prospective) 
consecutive patients with renal stones larger than 15 
mm treated with PCNL in the period from January 2020 
to March 2020 at the GH “8 September” – Skopje.
Pre-operative preparation of patients included: 
Medical history, complete blood count (hemoglobin, 
serum urea, creatinine, sodium, potassium, uric acid, 
albumin, protein, PTH, and Vitamin D3), urine sediment, 
tests for hemostasis and blood group, urine culture, 
electrocardiogram (12 drains), RTG of the heart and 
lungs, and consultation with an anesthesiologist. The 
degree of anesthesia risk was determined by the scale 
of the American Society of Anesthesiologists (ASA) [6].
Exclusion criteria were age of a patient under 
18 years and over 80 years, stones <15 mm, ASA index 
above III, presence of cardiovascular or pulmonary 
insufficiency, renal insufficiency, untreated urinary 
tract infection, renal abscess, congenital anomalies, 
including obstruction of the ureteropelvic junction 
or ureterovesical junction, presence of uncorrected 
coagulopathies, bilateral upper urinary tract obstruction, 
pregnant women, and radiolucent stones.
Before each intervention, an ultrasonographic 
examination of the ultrasonography (UT) and 
computerized tomography urography was performed to 
assess the size of the stones, the anatomical features 
of the kidney and its function, and to accurately plan 
the operative approach. The size of the stone was 
calculated based on the widest diameter of the CT 
urography series, and Hounsfield unit (HU) was 
measured for radiographic assessment of the stone 
density. The surface of the stones was determined by 
the formula by Tiselius and Anderson: The surface of 
the stones = length × width × 3.14 × 0.25.
With patients taking acetylsalicylic acid or 
other anticoagulants, they were discontinued for 
5–7 days before treatment. All patients undertook bowel 
preparation with macrogol 3350/80 mg simethicone the 
day before treatment according to the manufacturer’s 
protocol and were advised to discontinue the intake 
of any food the night before treatment. Patients with 
a bacterial infection detected by urine culture were 
treated with antibiotic therapy and operated on after 
receiving a sterile urine culture.
PCNL
Antibiotic prophylaxis with Amp. ceftriaxone 
2 g was prescribed preoperatively in all patients, as 
well as thromboembolic prophylaxis with low molecular 
weight heparin. The procedure began in the position of 
dorsal lithotomy before the main lithotripsy procedure, 
with a retrograde application of an open 5–6 Fr ureteral 
catheter that allowed the injection of contrast material 
to opacify and distend the collection system and 
perform artificial hydronephrosis. It was fixed for 18 
Fr Foley catheter. Next, the patient was repositioned 
and placed in a prone position on the operating table 
compatible with the C-arm. The radiation source was 
placed under the patient to minimize radiation exposure 
to the surgeon and medical staff.
After opacification of the collection system 
by injection of contrast material through the ureteral 
catheter, puncture of the pyelocaliceal system was 
performed using an 18 gauge puncture needle under 
fluoroscopic control. The most common puncture site 
was the lower calyx. The position at the top of the 
needle was checked by rotating the “C-arm” to 0° and 
30°. When it was established that the needle was in the 
calyx, the stylet was removed, and the exact position 
of the needle was confirmed by urine and contrast 
aspiration. Next through the puncture needle was 
placed 0.035″ working guidewire. The guidewire was 
placed under fluoroscopic control. Once the guidewire 
was well-positioned, the puncture needle was removed, 
and a 1 cm incision was made at the site of the wire. 
Next, the tract was extended through a guidewire with 
metal telescopic Alken dilators to 24-Fr. Through the last 
dilator, we introduced the working shirt of the endoscope 
(with a diameter of 26 Ch) and through it, we placed 
the nephroscope. In cases of complicated stones or 
difficulty in maintaining the percutaneous pathway, we 
used a second, safety guidewire as an adjunct to the 
initial working wire. Its purpose was to maintain access 
to the kidney if the working wire was bent or displaced. 
This safety wire was stored until the end of the whole 
surgical procedure. After placing the nephroscope, the 
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lithotripsy was performed with a dual, pneumatic and 
ultrasonic intracorporeal lithotripter, Swiss LithoClast 
Master, using the KarlStorz 24–26 fr nephroscope. 
During pneumatic lithotripsy, we used a pressure of 
3 atm and a frequency of 12 Hz, and during ultrasonic 
lithotripsy, we used a maximum level of sessions of 
60–100%. The ultrasound probe was placed through 
the nephroscope, and the pneumatic probe passed 
through it. After lithotripsy, we placed nephrostomy 
(Malecot 18–20 fr) and made a compression bandage. 
In the presence of nephrostomy tube hemorrhage, it 
was clamped for 1 h. We removed nephrostomy tube 
24-48 h after the operative treatment depending on 
the color of the contents in the drainage bag, and the 
ureteral probe and the Foley catheter, 48-72 h after 
treatment.
Postoperatively, the patients were monitored 
according to the following protocol:
•	 1st post-operative day: Complete blood count, 
urinary tract UT, and Kidney-Ureter-Bladder 
(KUB) X-ray
•	 After 7 days and 1 month: Urinary tract UT and 
KUB X-ray.
We defined the success of the treatment 
by determining the success rate – SR, the need for 
additional procedures, the degree of complications after 
treatment, the degree of blood loss by determining the 
difference between pre-operative and post-operative 
values of hemoglobin and hematocrit, and the duration 
of the procedure and time.
The effectiveness of the method was 
assessed by determining the absence of residual 
fragments from the stones or the presence of clinically 
insignificant fragments <4 mm on the control KUB 
X-ray examinations on the 1st and 30th post-operative 
day. The time of the operation was measured from 
the time of cystoscopic examination and placement 
of the ureteral probe to the end of the operation and 
the nephrostomy tube placement. The safety of the 
method was determined in terms of frequency and 
severity of intra and post-operative complications. 
The criterion for post-operative febrility was the 
increase in body temperature BT >38.5 in the post-
operative period without the presence of diagnostic 
criteria for sepsis. Intraoperative and post-operative 
complications were classified based on the modified 
Clavien-Dindo scale. Residual stones >4 mm were 
treated with ESWL and ureteral stones migrated to the 
lower urinary tract by ureterorenoscopy. The hospital 
stay was calculated from the day of the operation until 
the day of discharge.
Statistical analysis
The statistical analysis was performed with 
SPSS v.19.0 (SPSS Corporation, USA). Fisher’s 
exact test and Chi-square test were used to compare 
categorical variables and Student’s t-test to compare 
metric variables. The value of p < 0.05 was considered 
statistically significant.
Results
The presented results refer to the demographic 
and clinical characteristics, PCNL efficacy, perioperative 
blood loss, duration of the operative procedure, 
duration of hospital stay and intraoperative and post-
operative complications, the chemical composition of 
stones, and radiographic assessment of the density of 
the stones by HU. Percutaneous nephrolithotripsy was 
performed in all patients without overstressing the need 
for conversion to open surgery.
The pre-operative characteristics of patients, 
the basic clinical parameters, and stone characteristics 
are presented in Tables 1 and 2.
Table 1: Pre-operative characteristics of patients
Mean age (years ± SD) 52.35 ± 11.00
Gender (n/%)
Male 8 (57.1)
Female 6 (42.8)
Side (n/%)
Right kidney 5 (35.71)
Left kidney 9 (64.28)
Solitary kidney (n/%)
Contralateral nephrectomy 1 (7.14)
Contralateral kidney dysfunction 0
Mean BMI (kg/m² ± SD) 25.11 ± 3.92
Previous procedures (n/%)
Pyelolithotomy 1 (7.14)
ESWL 4 (28.57)
DJ 3 (21.42)
Mean length of stones (mm ± SD) 25.28 ± 5.58
Mean width of stones (mm ± SD) 18.21 ± 2.80
Mean surface area of stones (mm² ± SD) 371.24 ± 131.86
Mean pre-operative serum creatinine (mmol/l ± SD) 91.2 ± 15.98
Pre-operative serum Hg (g/dl ± SD) 13.94 ± 1.00
Pre-operative serum HCT (% ± SD) 42.49 ± 2.52
Pre-operative anesthetic risk by ASA (n/%)
ASA class 1 3 (21.42)
ASA class 2 9 (64.28)
ASA class 3 2 (14.28)
Features of stones (n/%)
Solitary stone 11 (78.57)
Multiple stones 1 (7.14)
Staghorn stone 2 (14.28)
Localization of the stones (n/%)
Renal pelvis 5 (35.71)
Upper calyces 2 (14.28)
Middle calyces 4 (28.57)
Lower calyces 3 (21.42)
Renal pelvis and lower calyces 0
Renal pelvis and upper calyces 0
Recurrent lithiasis (n/%) 1 (7.14)
Mean density of stones (HU ± SD) 949.78 ± 207.28
BMI: Body mass index, SD: Standard deviation, ESWL: Extracorporeal shock wave lithotripsy,  
HCT: Hematocrit, ASA: American Society of Anesthesiologists, HU: Hounsfield unit.
Table 2: Results
Parameters Pre-operative Post-operative p value
Serum Hg (g/dl ± SD) 13.94 ± 1.00 11.77 ± 1.51 0.00000124
Serum HCT (% ± SD) 42.49 ± 2.52 33.83 ± 4.11 0.00000002
Serum creatinine (mmol/l ± SD) 91.2 ± 15.98 86.9 ± 16.28 0.192
HCT: Hematocrit.
Despite the clinically significant difference in 
pre-operative and post-operative values of hemoglobin 
and hematocrit, (p = 0.00000124) and (p = 0.00000002), 
respectively, blood transfusion was not given to any 
of the patients because they were hemodynamically 
stable.
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The effectiveness of the procedure (SFR) 
on the 1st post-operative day evaluated by ultrasound 
diagnostics and KUB was 78.57%. Three patients 
postoperatively had clinically significant fragments 
>4 mm. Two patients were additionally treated with 
ESWL and one patient underwent ureterorenoscopy 
with lithotripsy due to migration of fragments into the 
distal ureter. The success rate on the 30th post-operative 
day, after additional procedures, was 92.85%. The 
average operating time in the entire series was 119.28 
± 9.42 min. The average hospital stay was 5.57 ± 1.11 
days. The average operative blood loss was 2.19 ± 
0.88 g/dl (Table 3).
Table 3: Results
SFR (n/%) 1st post-operative day 11/14 (78.57)
Success rate (n/%) 30th post-operative day 13/14 (92.85)
Mean operative time (min ± SD) 119.28 ± 9.42
Mean operative blood loss (g/dl ± SD) 2.19 ± 0.88
Mean hospital stay (days ± SD) 5.57 ± 1.11
Treatment of residual fragments (n/%)
ESWL 2 (14.28)
URS 1 (7.14)
Rehospitalization 0
SFR: Stone free rate, SD: Standard deviation, ESWL: Extracorporeal shock wave lithotripsy,  
URS: Ureteroscopy.
The chemical composition of the stones is 
shown in Table 4.
Table 4: Chemical composition (n/%)
Calcium oxalate monohydrate 6 (42.85)
Calcium oxalate dihydrate 4 (28.57)
Struvite 2 (14.28)
Brushite 1 (7.14)
Cystine 1 (7.14)
Postoperatively, analgesic therapy was 
required in the first 2 days after the procedure. We 
removed the transurethral catheter in the first 24–48 h, 
and the nephrostomy tube the next day. All operative 
interventions underwent without intraoperative 
complications. Post-operative complications included 
two cases of elevated BT >38.5°C and one case of more 
intense hematuria who was treated conservatively with 
Amp. Transamin (tranexamic acid) 1 g. These three 
severe complications were classified on the modified 
Clavien-Dindo scale as Grade I and II (Table 5).
Table 5: Complications
Type of complications n (%) The Clavien-Dindo classification
Intraoperative / /
Post-operative
Hematuria 1 (7.14) II
Febrility >38.5°C 2 (14.28) I
Treatment of complications
Medical therapy 3 (21.42)
Medical therapy + JJ stent
Discussion
In the age of modern medicine, thanks to the 
development of small caliber nephroscope as well as 
various types of intracorporeal lithotripters, treatment 
options for renal stones have changed dramatically and 
the indicative area of PCNL has expanded [7], [8]. Today, 
PCNL is not only the first choice in the treatment of stones 
>2 cm, as well as complicated renal stones (staghorn 
stones, multiple stones, and stones associated with 
abnormal renal anatomy) [9] but is a method for optimal 
treatment of medium-sized stones that are not treated 
with other less invasive methods [10].
In the European Association of Urology 
guidelines, the PCNL is recommended as a method of 
choice for renal stones larger than 20 mm while ESWL 
for renal stones <10 mm. ESWL, retrograde intrarenal 
surgery, and percutaneous nephrolithotomy (PCNL) are 
recommended as methods of choice in the treatment of 
renal stones between 10 and 20 mm. Which minimally 
invasive technique will be chosen depends on several 
factors affecting the treatment of renal stones, which 
can be grouped into four categories [11].
•	 Factors related to stones: Localization, size, 
number, and chemical composition.
•	 Anatomical factors of the kidney: Obstruction 
or stasis, hydronephrosis, stenosis of the 
ureteropelvic junction, calyx diverticula, 
horseshoe kidney, renal ectopia or fusion, and 
lower pole stones.
•	 Clinical factors: Infections, obesity, body 
deformities, coagulopathies, hypertension, 
and renal failure.
•	 Technical factors: Availability of modern 
treatment instruments, operator experience, 
patient requirements, physician preferences, 
method success rate, treatment complications, 
and cost [12].
Conventionally, in PCNL the patient is in a 
prone position. Prone position provides a larger area 
for puncture selection, including a puncture of the 
upper calyx, wider space for manipulation with the 
nephroscope and lithotripter, and a lower risk of perirenal 
visceral injury [13]. However, there are drawbacks to 
performing PCNL in the traditional prone position such 
as patient discomfort, relatively long intervention time 
due to patient repositioning, anesthetic risks including 
circulatory problems, respiratory difficulties, suboptimal 
airway control, increased sympathetic activity, and 
possible lesions of the cervical spine or peripheral 
nerves [14].
In a study conducted in the United Kingdom 
by Armitage et al. [15] in 1028 patients, PCNL was 
performed in the prone position and only in 6% it was 
performed in the supine position.
In our study, all procedures were performed 
in a prone position; percutaneous renal access was 
performed by a urologist under fluoroscopic control. 
In 12 (85.7%) patients, renal access was performed 
through the lower calyx, in 1 (7.14%) patient through 
the middle calyx and in 1 (7.14%) patient through the 
upper calyx. The choice of approach depended on the 
location of the stones.
In a study by El-Assmy et al. [16], it is noted 
that the results of a renal approach performed by a 
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urologist are equal to or better than the renal approach 
performed by a radiologist. Our findings confirm this, the 
right approach is a prerequisite for complete success in 
extracting renal stones with PCNL. The ideal tract is the 
one that provides the shortest and simplest access to 
all stones.
Renal access to the upper calyx, which is most 
commonly performed in the 11th and 12th intercostal 
spaces, is associated with multiple complications due to 
the proximity of the upper calyx to the lungs. Therefore, 
pneumothorax, pleural effusion, and calico-pleural 
fistulas are more commonly seen with access to the 
upper calyx, and pulmonary complications have been 
reported in almost a quarter of patients undergoing 
intercostal access [17]. Only in one patient in our study 
was the approach supracostal, with no post-operative 
complications present.
As with other minimally invasive techniques, 
PCNL is constantly evolving and advancing. Dilatation 
of the renal route for establishing intrarenal access 
is one of the most important steps during PCNL. 
Since the introduction of the first nephrostomy in 
1955, this technique has developed steadily, leading 
to an improvement in the outcome of percutaneous 
nephrolithiasis. [18], [19], [20].
In 1994, Stoller et al. [21] examined the effects 
of the Alken coaxial metal dilators and balloon dilators on 
blood loss, with no significant differences found between 
the two methods. A study by Kukreja et al. [22] compared 
the Amplatz dilators, Alken coaxial metal dilators, and 
balloon dilators. There was less blood loss with the 
use of the Amplatz dilators, but without a statistically 
significant difference between them.
In our series, the Alken metal dilators were 
used and our results in terms of blood loss and safety 
did not differ from the results of Stoller and Kukreja’s 
study using metal coaxial dilators.
The average operating time in our study was 
119.28 ± 9.42 min, which is similar to the time reported 
by Kurtulus et al. (2.2 h) [23]. Gupta et al. [24] reported 
a mean operating time of 80.2 min. Falahatkar et al. [25] 
also reported a mean operating time of 67.42 ± 26.25 
min. In a series of 10 cases of outpatient post-operative 
patients after PNL, Singh et al. [26] had a mean 
operating time of 48.4 min. In the study of Shahrour and 
Andonian [27], the mean operating time was 83.5 min.
The longer operating time in our study can be 
explained by the fact that our procedures were initial in 
the implementation of PCNL as a method in our institution 
and were performed by surgeons with an initial level of 
experience. Furthermore, we calculated the time interval 
from the initial placement of the ureteral catheter to the 
fixation of the nephrostomy tube. It should also be noted 
that we performed subsequent dilatation when establishing 
the intrarenal route with metal coaxial dilators.
In our study, the effectiveness of the method 
was assessed by determining the absence of residual 
fragments from the stones (SFR), or the presence 
of clinically insignificant fragments <4 mm of control 
KUB X-ray examinations on the 1st, 7th, and 30th post-
operative day.
In the study of Albala et al. [28], the success 
of the treatment is defined in terms of the absence of 
residual fragments (SFR), or the presence of clinically 
insignificant fragments ≤3 mm in diameter relative to the 
initial size of the stones, at the end of the 3rd month, at 
which the success rate of 95% for PCNL was achieved. 
In the Giusti and Shoma studies, the overall SFR was 
95.4 and 92%, respectively [29], [30]. A study by Bayar 
et al. [31] compared the results of PCNL performed 
for isolated stones in the renal pelvis, upper and lower 
group of calyces on the one hand, and complex stones 
on the other, with success rates of 77% for isolated and 
53% for complex stones. 
In our study, the initial SFR for the 1st post-
operative day was 78.57%, while the overall success 
rate for the 30th post-operative day was 92.85%. This 
result is consistent with Shoma’s result. The lower 
success rate than the results of Albala et al. and 
Giusti et al. is probably due to our significantly lesser 
experience with this method. The treatment of residual 
fragments depended on the location and their size. 
URS was performed in one (7.14%) patient and ESWL 
in 2 (14.28%) patients with total rates of additional 
procedures of 3 (21.42%). These results are consistent 
with the results in the literature.
The overall incidence of complications 
after PCNL is small. Bleeding is the most significant 
complication of PCNL, with transfusion rates ranging 
from 1% to 10%. Bleeding from an arteriovenous fistula 
or pseudoaneurysm requires immediate embolization 
and occurs in less than 0.5% of patients. Acute 
hemorrhage is usually venous in nature, and in most 
cases, the clamping of the placed nephrostomy tube 
is sufficient to control it. In PCNL, absorption of the 
irrigation medium may occur, which is why it is necessary 
to use saline as a means of irrigation. In supracostal 
puncture, there is a risk of pneumothorax, hemothorax, 
and pleural effusion, and in 4–12% of cases, pleural 
drainage is required. Colon injury is a rare complication, 
often diagnosed with a post-operative nephrostogram 
and may be retroperitoneal and intraperitoneal. The 
most common complications of PCNL are fever, 
bleeding, and prolonged leakage of urine through the 
renal approach [32].
In the research of Netto et al. [33] in a series 
of 119 patients, the complication rate was 28.5%. The 
most common major complications were bleeding 
requiring blood transfusion (n = 25), pneumothorax-
hydrothorax (n = 2), sepsis-bacteremia (n = 2), ileus 
(n = 2), and prolonged urine leakage (n = 2). In the study 
of Tefekli et al. [34], the total incidence of complications 
graded according to the Clavien-Dindo scale with 
grades 3–5 was 10.5%, while for grades 1 and 2, the 
total complication rate was 20.3%.
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In a Troxel and Low [35] study of 128 patients, 
42.4% of patients had a temperature higher than 
38.5°C, although all patients received pre-operative 
and post-operative antibiotic prophylaxis.
In our study, none of the cases had a 
complication of Grade III, IV, or V on the Clavien-Dindo 
scale. This is due to the fact that this is a group of well-
selected cases with moderate-sized kidney stones. 
Post-operative complications were classified according 
to the Clavien-Dindo scale, Grade I and II. Prolonged 
hematuria but without the need for transfusion was 
observed in 1 (7.14%) patient. (Clavien-Dindo II) while 
elevated post-operative TT was observed in 2 (14.28) 
patients. (Clavien-Dindo I) The temperature was higher 
than 38.5°C, and it was treated with antibiotics and 
antipyretics. The overall complication rate was 21.42%, 
according to the study by Tefekli et al.
No significant intraoperative complications were 
observed in this study. Intraoperative bleeding occurred 
in 1 (7.14%) patient. The bleeding was minor and 
originated in the accessory tract, requiring neither blood 
transfusion nor embolization. The patient nephrostomy 
tube (Malecot 24 Fr) was clamped in a period of 1 h for 
tamponade and stopping the hemorrhage.
The smaller rate of complications in our study 
is probably due to a small group of highly selected 
patients. The majority of patients had an isolated stone 
in the renal pelvis with consequent hydronephrosis, and 
the lower calyx was most commonly punctured.
We used the difference between pre-operative 
and post-operative hemoglobin levels as an indicator of 
blood loss, the average reduction in hemoglobin level 
was 2.19 g/dl, which was higher than the results of a 
study by Shaban et al. [36] where the fall in hemoglobin 
was 0.79 g/dl. Despite the higher blood loss value in 
this study, none of the patients in our series received 
a blood transfusion because the hemoglobin drop was 
not below 9 g/dl and all patients were hemodynamically 
stable.
In the current study, the mean length of hospital 
stay was (5.57 ± 1.11 days). Similar results in terms of 
hospital stay are shown in the study of Giusti et al. [29], 
where the mean hospitalization at standard PCNL is 5.3 
days. Albala et al. [28] reported an average hospital stay 
of 2.66 days, while Netto et al. [33] reported 3.1 days.
The small number of patients is the main 
limiting factor in this study. The study also included the 
initial PCNL, which is another limiting factor.
Conclusion
The results of this retrospectively prospective 
study confirm that PCNL is a minimally invasive, 
harmless, safe, and effective method for removing renal 
stones. This method, with the development of new 
technologies, has an increasingly important role in the 
modern surgical treatment of nephrolithiasis. PCNL can 
also be performed in the early stages of the learning 
curve without compromising patient safety and treatment 
benefits. The procedure is safe and effective, performed 
even by less experienced urologists if the protocols 
established for this procedure are followed. This can 
achieve a rate of success comparable to most established 
standards without causing major complications.
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